Two publications this week:

• The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders | link
• Key drivers of family-level utility of pediatric genomic sequencing: a qualitative analysis to support preference research | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications this week:

• Genomics and Insurance in the United Kingdom: Increasing Complexity and Emerging Challenges | link
• Cost of exome analysis in patients with intellectual disability: a micro-costing study in a French setting | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication this week:

• Retrospective file review shows limited genetic services fails most patients – an argument for the implementation of exome sequencing as a first-tier test in resource-constraint settings | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication this week:

• Rapid exome sequencing as a first-tier test in neonates with suspected genetic disorder: results of a prospective multicenter clinical utility study in the Netherlands | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications this week:

• Micro-costing diagnostic genomic sequencing: a systematic review | link
• Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator: A systematic review | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication this week:

• Economic evaluation of next-generation sequencing techniques in diagnosis of genetic disorders: A systematic review | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication this week:

• A systematic review of economic evaluations of whole-genome sequencing for the surveillance of bacterial pathogens | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications since 14th December:

• A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice | link
• Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Weekly updates will return from this week onwards.

One publication from the past week:

• The PrU: development and validation of a measure to assess personal utility of genomic results | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

There will be no posts for the next two weeks due to the Christmas break. The next post will be on 3rd January.

Three publications from the past week:

• Cost-effectiveness of a gene sequencing test for Alzheimer’s disease in Ontario | link
• Key drivers of family-level utility of pediatric genomic sequencing: a qualitative analysis to support preference research | link
• A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.